Related Experiment Videos
Spontaneous vertigo and headache: endolymphatic hydrops or migraine?
1Balance Care Center, Ear, Nose, and Throat Associates, 10021 Dupont Circle Ct., Fort Wayne, IN 46825, USA. Boismier@fwi.com
Ear, Nose, & Throat Journal
|January 5, 2002
Summary
Patients with vertigo and headache may benefit from initial treatment for endolymphatic hydrops. A stepwise approach, starting with hydrops therapy, is recommended for these complex cases.
Area of Science:
- Neurology
- Otolaryngology
Background:
- Differentiating between endolymphatic hydrops and migraine in patients with concurrent vertigo and headache is clinically challenging.
- Identifying predictive characteristics for each condition can aid in targeted treatment.
Purpose of the Study:
- To assess treatment response in patients with spontaneous vertigo and headache, comparing endolymphatic hydrops therapy versus migraine therapy.
- To identify patient characteristics that may predict either endolymphatic hydrops or migraine.
Main Methods:
- Initial treatment for all patients involved sodium restriction and increased water intake for endolymphatic hydrops.
- Treatment response was evaluated using the Dizziness Handicap Inventory, a symptom severity scale, and a disability scale.
- Non-responders to endolymphatic hydrops treatment were subsequently treated for migraine.
Main Results:
- Out of 23 analyzed patients, 14 (60.9%) improved with initial endolymphatic hydrops treatment.
- Six patients (26.1%) improved after switching to migraine treatment.
- Three non-compliant patients showed no improvement, suggesting treatment efficacy.
Conclusions:
- A stepwise treatment strategy, commencing with endolymphatic hydrops therapy, appears appropriate for patients with vertigo and headache.
- While not statistically significant due to sample size, trends suggest predictive patient characteristics exist.
- Treatment compliance is crucial for symptom improvement in these patients.